Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

UK pharmaceutical giants AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) shares both avoided the wider sell-off on Thursday morning on hopes that...…

AstraZenecas new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.…

31 March 2025 Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line…

31 March 2025 Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer  Based on NIAGARA Phase III…

…

Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust…

The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

In the most recent trading session, Astrazeneca (AZN) closed at $72.72, indicating a -0.45% shift from the previous trading day.…

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities broadly…

Pharmaceutical company will invest money over five years in ‘strategic partnership’ with the city’s authorities…

Der britische Pharmakonzern baut seine Präsenz im chinesischen Markt mit einem 2,5-Milliarden-Dollar Forschungszentrum in Peking aus, was Anleger vorerst skeptisch…

AstraZeneca has shown its commitment to China amid investigations into its executives and activities,…

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the…

AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals…

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing,…